D-0026-2022 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0026-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 5, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle. The recall status is terminated (terminated Dec 6, 2022). Affected quantity: 8,976 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 27, 2021
Initiation Date
Oct 5, 2021
Termination Date
Dec 6, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,976 bottles

Product description

Omeprazole Delayed-Release Capsules, 20 mg* (equivalent to 20.6 mg omeprazole magnesium), 24 Hour, 14-count capsules per bottle within a carton, Distributed by Cardinal Health, Dublin, OH 43017, NDC 70000-0232-1

Reason for recall

CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.

Distribution pattern

Nationwide in the USA

Code information

BT001594C

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0026-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0026-2022. Report a data issue: hello@regdatalab.com.